NgoziEronduMD

PubMed

• 11 citations
  How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
  Tieble Traore, Sarah Shanks, Najmul Haider, Kanza Ahmed, Vageesh Jain, Simon R Rüegg, Ahmed Razavi, Richard Kock, Ngozi Erondu, Afifah Rahman-Shepherd, Alexei Yavlinsk...> ;Lancet. 2023 Feb 25
• 4 citations
  Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study.
  Vivek A Rudrapatna, Yao-Wen Cheng, Colin Feuille, Arman Mosenia, Jonathan Shih, Yongmei Shi, Olivia Roberson, Benjamin Rubin, Atul J Butte, Uma Mahadevan, Nicholas Sko...> ;Plos One. 2023 Jan 1
• 392 citations
  Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
  Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D. Barrett, Michele A. Weidner-Wells, Hsiaowei Deng, David R. Matt...> ;The Lancet. Diabetes & Endocrinology. 2018 Sep 1
• 309 citations
  Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
  Kenneth W. Mahaffey, Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Elisa Fabbrini, Tao Sun, Qiang Li, Mehul Desai, David R. Matthews> ;Circulation. 2017 Nov 13
• 67 citations
  Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial
  Priscilla Hollander, Harold E. Bays, Julio Rosenstock, Mary Ellen Frustaci, Albert Fung, Frank Vercruysse, Ngozi Erondu> ;Diabetes Care. 2017 May 1
• 86 citations
  Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
  Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Mehul Desai, Wayne Shaw, Gordon Law, Marc K. Walton, Norm Rosenthal, Dick de Zeeuw, David ...> ;Diabetes, Obesity & Metabolism. 2017 Jul 1
• 264 citations
  Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R) : A randomized, placebo-controlled trial
  Bruce Neal, Vlado Perkovic, David R. Matthews, Kenneth W. Mahaffey, Greg Fulcher, Gary Meininger, Ngozi Erondu, Mehul Desai, Wayne Shaw, Frank Vercruysse, Jacqueline Y...> ;Diabetes, Obesity & Metabolism. 2017 Mar 1
• 46 citations
  Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases.
  Ajay Nirula, Jon Nilsen, Paul Klekotka, Greg Kricorian, Ngozi Erondu, Jennifer E. Towne, Chris B. Russell, David Martin, Alison L. Budelsky> ;Rheumatology. 2016 Dec 1
• 14 citations
  Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis.
  Philip J. Mease, Mark C. Genovese, Alex Mutebi, Hema N. Viswanathan, Dina Chau, J. Feng, Ngozi Erondu, Ajay Nirula> ;The Journal of Rheumatology. 2016 Feb 1
• Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
  Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger> ;Diabetes Care. 2016 Jan 1
• 3 citations
  Reliability and validity of the psoriasis symptom inventory in patients with psoriatic arthritis
  Hilary Wilson, Alex Mutebi, Dennis A. Revicki, Philip J. Mease, Mark C. Genovese, Ngozi Erondu, Ajay Nirula, Feng Jing Yuan, Hema N. Viswanathan> ;Arthritis Care & Research. 2015 Dec 1
• 564 citations
  Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
  Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Weglowska, Lluís Puig, Kim A. Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Arms...> ;The New England Journal of Medicine. 2015 Sep 30
• 221 citations
  Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
  Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger> ;Diabetes Care. 2015 Sep 1
• 62 citations
  Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis
  Hema N. Viswanathan, Dina Chau, Cassandra E Milmont, Wenjjing Yang, Ngozi Erondu, Dennis A. Revicki, Paul Klekotka> ;The Journal of Dermatological Treatment. 2015 Jul 22
• 52 citations
  A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
  Karel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner, Ngozi Erondu> ;The Journal of Rheumatology. 2015 Apr 15
• 22 citations
  Evaluation of the Pharmacokinetic Interaction between Repeated Doses of Rifapentine or Rifampin and a Single Dose of Bedaquiline in Healthy Adult Subjects
  Helen Winter, Erica Egizi, Stephen Murray, Ngozi Erondu, Ann M. Ginsberg, Doris J. Rouse, Diana Severynse-Stevens, Elliott Pauli> ;Antimicrobial Agents and Chemotherapy. 2015 Feb 1
• 285 citations
  Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
  Philip J. Mease, Mark C. Genovese, Maria Greenwald, Christopher T. Ritchlin, André D. Beaulieu, A. A. Deodhar, Richard Newmark, Jing Yuan Feng, Ngozi Erondu, Ajay Nirula> ;The New England Journal of Medicine. 2014 Jun 11
• 24 citations
  A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet.
  Thomas A. Wadden, Ken Fujioka, Søren Toubro, Ira Gantz, Ngozi Erondu, Menghui Chen, Shailaja Suryawanshi, Wendy L. Carofano, Amy O. Johnson-Levonas, Deborah R. Shapiro...> ;Obesity. 2010 Dec 1
• 5 citations
  Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist.
  Xiujiang Susie Li, Jace Nielsen, Brenda Cirincione, Hankun Li, Carol Addy, John A. Wagner, Alan Hartford, Ngozi Erondu, Ira Gantz, Jerry D. Morgan, Julie A. Stone> ;The AAPS Journal. 2010 Jun 26
• 38 citations
  A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
  M. S. Kipnes, Priscilla Hollander, Ken Fujioka, Ira Gantz, Thomas Seck, Ngozi Erondu, Yue Shentu, Kaifeng Lu, Shailaja Suryawanshi, M. Z. Chou, Amy O. Johnson-Levonas,...> ;Diabetes, Obesity & Metabolism. 2010 Jun 1
• 53 citations
  A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.
  Joseph Proietto, Aila Rissanen, J B Harp, Ngozi Erondu, Q Yu, Shailaja Suryawanshi, Mark E Jones, Amy O. Johnson-Levonas, S. B. Heymsfield, Keith D. Kaufman, John M. A...> ;International Journal of Obesity. 2010 Mar 9
• 60 citations
  A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
  Louis J. Aronne, S Tonstad, M. Moreno, Ira Gantz, Ngozi Erondu, Shailaja Suryawanshi, Cliona Molony, Solveig K. Sieberts, J. Nayee, Alan G. Meehan, Deborah R. Shapiro,...> ;International Journal of Obesity. 2010 Feb 16
• 73 citations
  One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures.
  Ronette L. Kolotkin, Josephine M. Norquist, Ross D. Crosby, Shailaja Suryawanshi, Pedro J. Teixeira, Steven B. Heymsfield, Ngozi Erondu, Allison Martin Nguyen> ;Health and Quality of Life Outcomes. 2009 Jun 9
• 60 citations
  Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis.
  Anthony N. Fabricatore, Thomas A. Wadden, Reneé H. Moore, Meghan L. Butryn, Elizabeth A. Gravallese, Ngozi Erondu, Steven B. Heymsfield, Allison Martin Nguyen> ;Obesity Reviews. 2009 May 1
• 1 citations
  Assessment of disaster training needs for physicians and other health professionals serving vulnerable populations in Hawai'i.
  May Rose Dela Cruz, Brandon Mitsuda, Amalie Monlux, Khris Agnos, Angel Ahedo, Lila Au, Ngozi Erondu, Arline Harmon, Pedro Haro-Arvizu, Barbara Kualii, Clare Loprinzi, ...> ;Hawaii Medical Journal. 2008 Mar 1
• Join now to see all